Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
Clinical trial NCT00558844 · COMPLETED
Trial details
- NCT number
- NCT00558844
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.